![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, June 08, 2023 5:11:11 PM
Thrilled to announce the start of an investigator initiated study evaluating our FDA cleared device for its ability to also reduce pain in patients with thumb carpometacarpal (CMC) joint osteoarthritis (OA). Stanford University initiated a study entitled "Pulsed Electromagnetic Field (PEMF) Therapy in Thumb CMC Arthritis" (ClinicalTrials.gov Identifier: NCT05315297) Osteoarthritis is the second-most common musculoskeletal disorder, leading to pain and functional limitations with a high social and economic burden. OA can affect every joint in the body, but it is most common in the knee, hip, spine, and hand. Within the hand, the thumb base is the most affected single joint. (https://lnkd.in/e-jPdpqF) #clinicaltrial #osteoarthritis #painrelief #painmanagement #drugfreetreatment #stanforduniversity #research $BIEL
pknopick@eandecommunications.com
6/8/2023 4:20:57 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM